hydromorphone has been researched along with etomidate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cerza, RF | 1 |
| Calbay, R; da Cunha, AF; Hofmeister, EH; Jones, TL | 1 |
1 review(s) available for hydromorphone and etomidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for hydromorphone and etomidate
| Article | Year |
|---|---|
Descriptive assessment of adverse events associated with midazolam-etomidate versus saline-etomidate in healthy hydromorphone premedicated dogs.
Topics: Anesthetics, Intravenous; Animals; Dog Diseases; Dogs; Etomidate; Hydromorphone; Midazolam; Myoclonus | 2021 |
3 other study(ies) available for hydromorphone and etomidate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Beta-selective monoamine oxidase inhibitors and cardiac anesthesia.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Anesthetics, Inhalation; Anesthetics, Intravenous; Aortic Valve; Coronary Artery Bypass; Drug Interactions; Etomidate; Female; Heart Valve Prosthesis; Humans; Hydromorphone; Hypnotics and Sedatives; Lorazepam; Monoamine Oxidase Inhibitors; Morphine; Selegiline | 1995 |